HK1087115A1 - Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors - Google Patents
Sulfamate benzothiophene derivatives as steroid sulfatase inhibitorsInfo
- Publication number
- HK1087115A1 HK1087115A1 HK06107352.1A HK06107352A HK1087115A1 HK 1087115 A1 HK1087115 A1 HK 1087115A1 HK 06107352 A HK06107352 A HK 06107352A HK 1087115 A1 HK1087115 A1 HK 1087115A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- steroid sulfatase
- benzothiophene derivatives
- sulfatase inhibitors
- sulfamate benzothiophene
- sulfamate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/76—Dibenzothiophenes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Materials For Photolithography (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2003/008811 WO2004101545A1 (en) | 2003-05-16 | 2003-05-16 | Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1087115A1 true HK1087115A1 (en) | 2006-10-06 |
Family
ID=33442621
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK06107352.1A HK1087115A1 (en) | 2003-05-16 | 2006-06-29 | Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors |
Country Status (22)
Country | Link |
---|---|
US (1) | US7476691B2 (xx) |
EP (1) | EP1644350B1 (xx) |
JP (1) | JP4757497B2 (xx) |
CN (2) | CN100491370C (xx) |
AP (1) | AP2066A (xx) |
AT (1) | ATE435221T1 (xx) |
AU (1) | AU2003260390B2 (xx) |
BR (1) | BR0318295A (xx) |
CA (1) | CA2525684C (xx) |
CY (1) | CY1109371T1 (xx) |
DE (1) | DE60328233D1 (xx) |
DK (1) | DK1644350T3 (xx) |
ES (1) | ES2329241T3 (xx) |
HK (1) | HK1087115A1 (xx) |
IL (1) | IL171763A (xx) |
MX (1) | MXPA05012300A (xx) |
NO (1) | NO20055749L (xx) |
NZ (1) | NZ544013A (xx) |
PT (1) | PT1644350E (xx) |
SI (1) | SI1644350T1 (xx) |
TN (1) | TNSN05291A1 (xx) |
WO (1) | WO2004101545A1 (xx) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
OA13336A (en) | 2003-12-15 | 2006-04-13 | Theramex | 1-N-phenyl-amino-1H-imidazole derivatives and pharmaceutical compositions containing them. |
GB0511190D0 (en) * | 2005-06-01 | 2005-07-06 | Sterix Ltd | Use |
AU2007271486A1 (en) * | 2006-07-05 | 2008-01-10 | Merck Patent Gmbh | Sulfamate benzothiophene derivatives |
WO2008067892A1 (de) * | 2006-12-04 | 2008-06-12 | Merck Patent Gmbh | Sulfamat-benzothiophen-derivate |
BRPI0817045A2 (pt) * | 2007-09-17 | 2015-03-24 | Preglem Sa | Tratamento de condições estrogênio-dependentes em mulheres pré-menopáusicas |
JP2011157371A (ja) * | 2011-03-17 | 2011-08-18 | Lab Theramex | ステロイドスルファターゼ阻害剤としてのベンゾチオフェンスルファミン酸塩誘導体 |
CN115805103B (zh) * | 2021-09-14 | 2024-04-09 | 万华化学集团股份有限公司 | 一种失活钛硅分子筛的再生方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9118478D0 (en) * | 1991-08-29 | 1991-10-16 | Imperial College | Steroid sulphatase inhibitors |
US6248780B1 (en) * | 1998-10-01 | 2001-06-19 | Duquesne University Of The Holy Ghost | Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same |
-
2003
- 2003-05-16 ES ES03816954T patent/ES2329241T3/es not_active Expired - Lifetime
- 2003-05-16 BR BRPI0318295-9A patent/BR0318295A/pt not_active IP Right Cessation
- 2003-05-16 US US10/555,780 patent/US7476691B2/en not_active Expired - Fee Related
- 2003-05-16 NZ NZ544013A patent/NZ544013A/en not_active IP Right Cessation
- 2003-05-16 PT PT03816954T patent/PT1644350E/pt unknown
- 2003-05-16 SI SI200331665T patent/SI1644350T1/sl unknown
- 2003-05-16 AT AT03816954T patent/ATE435221T1/de active
- 2003-05-16 DK DK03816954T patent/DK1644350T3/da active
- 2003-05-16 CN CNB038264706A patent/CN100491370C/zh not_active Expired - Fee Related
- 2003-05-16 DE DE60328233T patent/DE60328233D1/de not_active Expired - Lifetime
- 2003-05-16 JP JP2004571781A patent/JP4757497B2/ja not_active Expired - Fee Related
- 2003-05-16 CN CNA2009100023017A patent/CN101508691A/zh active Pending
- 2003-05-16 EP EP03816954A patent/EP1644350B1/en not_active Expired - Lifetime
- 2003-05-16 AP AP2005003468A patent/AP2066A/en active
- 2003-05-16 CA CA2525684A patent/CA2525684C/en not_active Expired - Fee Related
- 2003-05-16 AU AU2003260390A patent/AU2003260390B2/en not_active Ceased
- 2003-05-16 MX MXPA05012300A patent/MXPA05012300A/es active IP Right Grant
- 2003-05-16 WO PCT/EP2003/008811 patent/WO2004101545A1/en active Application Filing
-
2005
- 2005-11-03 IL IL171763A patent/IL171763A/en not_active IP Right Cessation
- 2005-11-15 TN TNP2005000291A patent/TNSN05291A1/en unknown
- 2005-12-05 NO NO20055749A patent/NO20055749L/no not_active Application Discontinuation
-
2006
- 2006-06-29 HK HK06107352.1A patent/HK1087115A1/xx not_active IP Right Cessation
-
2009
- 2009-09-09 CY CY20091100937T patent/CY1109371T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CY1109371T1 (el) | 2014-07-02 |
AU2003260390B2 (en) | 2010-05-20 |
CN100491370C (zh) | 2009-05-27 |
CN101508691A (zh) | 2009-08-19 |
ATE435221T1 (de) | 2009-07-15 |
DK1644350T3 (da) | 2009-11-23 |
WO2004101545A1 (en) | 2004-11-25 |
EP1644350B1 (en) | 2009-07-01 |
CA2525684A1 (en) | 2004-11-25 |
NO20055749L (no) | 2005-12-14 |
SI1644350T1 (sl) | 2009-12-31 |
DE60328233D1 (de) | 2009-08-13 |
CN1771243A (zh) | 2006-05-10 |
TNSN05291A1 (en) | 2007-07-10 |
AP2005003468A0 (en) | 2005-12-31 |
JP4757497B2 (ja) | 2011-08-24 |
NO20055749D0 (no) | 2005-12-05 |
US7476691B2 (en) | 2009-01-13 |
BR0318295A (pt) | 2006-07-11 |
IL171763A (en) | 2013-09-30 |
AU2003260390A1 (en) | 2004-12-03 |
ES2329241T3 (es) | 2009-11-24 |
NZ544013A (en) | 2009-04-30 |
CA2525684C (en) | 2015-01-06 |
AP2066A (en) | 2009-11-27 |
MXPA05012300A (es) | 2006-01-30 |
US20070021492A1 (en) | 2007-01-25 |
EP1644350A1 (en) | 2006-04-12 |
JP2006525947A (ja) | 2006-11-16 |
PT1644350E (pt) | 2009-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL176554A0 (en) | Thiophene derivatives as chk 1 inhibitors | |
ZA200700181B (en) | Aryl-pyridine derivatives as 11-beta-HSD1 inhibitors | |
ZA200702394B (en) | Indozolone derivatives as 11b-HSD1 inhibitors | |
IL180962A0 (en) | Novel thiophene derivatives | |
PL1802579T3 (pl) | Pochodne 3-aryloaminopirydynowe | |
AP2006003768A0 (en) | TetraazabenzoÄeÜazulene derivatives and analogs tehereof | |
AP2074A (en) | New 4-benzylidene-piperidin derivatives | |
IL177968A0 (en) | Tetrahydropyridoindole derivatives | |
HK1105971A1 (en) | Pyrrazolo-pyrimidine derivatives | |
EP1810965A4 (en) | HYDRAZIDE DERIVATIVES | |
IL183140A0 (en) | Substituted benzoquinolizine derivatives | |
IL182585A0 (en) | Imidazo-benzodiazepine derivatives | |
IL183142A0 (en) | New pyridothienopyrimidine derivatives | |
HK1087115A1 (en) | Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors | |
IL183141A0 (en) | New pyridothienopyrimidine derivatives | |
HK1100002A1 (en) | 4-phenyl-pyrimidine-2-carbonitrile derivatives | |
ZA200703674B (en) | Acylated nonadepsipeptides used as lysobactin derivatives | |
HK1100775A1 (en) | 4-Amino-5-cyanopyrimidine derivatives | |
GB0414272D0 (en) | OsK1 derivatives | |
IL182001A0 (en) | 2-acylaminothiazole derivatives | |
GB2410745B (en) | Cholestanyl derivatives | |
ZA200509653B (en) | Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors | |
PL378930A1 (pl) | Pochodne aminosulfonianu benzotiofenu jako inhibitory sulfatazy steroidowej | |
AU2003232362A8 (en) | 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors | |
PL379168A1 (pl) | Pochodne kaptoprilu |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20130516 |